Use of Bedside Ultrasonography on the Incidence of Acute Renal Failure in High-risk Surgical Patients
NCT ID: NCT03509935
Last Updated: 2020-07-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
111 participants
INTERVENTIONAL
2018-03-12
2019-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Bedside Renal Ultrasound Assessment in Patients With Acute Kidney Injury
NCT06156098
Ultrasound Markers of Organ Congestion in Severe Acute Kidney Injury
NCT04095143
The Diagnostic Value of Contrast-enhanced Ultrasound in Acute Kidney Injury in ICU
NCT06353659
Ultrasound to Evaluate Acute Kidney Injury
NCT06241417
Establish and Apply the Evaluation System of Ultrasonic Integrated Technology for Prevention and Treatment of Acute Kidney Injury
NCT02347930
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention Ultrasound Group
Patients will be submitted to Ultrasound protocol, namely:
1. In the first 6 to 12 hours of admission to ICU
2. Second US after 12-24 hours of inclusion.
3. Third US after 24-48 hours of inclusion.
Protocol:
* US 4 pulmonary quadrants in each hemithorax: anterior and lateral, upper and lower regions.
* US inferior vena cava, collapsability or distensibility index according to the patient's conditions, in spontaneous or controlled ventilation, respectively.
* Cardiac US: subjective evaluation of contractility between normal, reduced or severely reduced.
The US findings will be communicated to the attending physicians who will conduct the patient, according to the protocol, recommending the administration of volume or not, and the use of vasopressors and/or inotropic drugs.
Intervention Ultrasound Group
Protocol:
* US 4 pulmonary quadrants in each hemithorax: anterior and lateral, upper and lower regions (figure 1)
* US inferior vena cava, collaborative index or distensibility according to the patient's conditions, in spontaneous or controlled ventilation, respectively.
* Cardiac US: subjective evaluation of contractility in normal, discreetly reduced or severely reduced.
Control Group
Patients randomized to this group will receive care according to the indication of the attending physicians, composed mainly of intensive care physicians, without bedside US. Patients may be submitted to echocardiographic, abdominal and vascular examinations, among others, requested to ultrasound service, according to the indication.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intervention Ultrasound Group
Protocol:
* US 4 pulmonary quadrants in each hemithorax: anterior and lateral, upper and lower regions (figure 1)
* US inferior vena cava, collaborative index or distensibility according to the patient's conditions, in spontaneous or controlled ventilation, respectively.
* Cardiac US: subjective evaluation of contractility in normal, discreetly reduced or severely reduced.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Major surgeries requiring ICU admission associated with one of the following criteria:
* Use of vasoactive drugs
* Use of inotropic drugs
* Mean blood pressure less than 65 mmHg or SBP \<90 mmHg.
* Hyperlactatemia\> 2 mmol / L
* Heart rate\> 90 bpm.
* Invasive mechanical ventilation required for at least 6 hours at the time of inclusion.
* Hypoxia: satO2 \<92% in ambient air.
* Length of surgery greater than 4 hours.
* Request for transfusion of blood products in a surgical block
* Oliguria during procedure, defined as diuresis \<0.5 ml/kg/h.
Exclusion Criteria
* Dying patients with impending death in the first 24 hours
* Patients in a previous renal replacement therapy program
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Federal University of Minas Gerais
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Vandack Alencar Nobre
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Vandack Nobre, PhD
Role: PRINCIPAL_INVESTIGATOR
Hospital das Clincias UFMG
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital das Clínicas - Universidade Federal de Minas Gerais
Belo Horizonte, Minas Gerais, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
US to guide ressuscitation
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.